ClinConnect ClinConnect Logo
Search / Trial NCT05655065

Effects of Increasing Mean Arterial Pressure on Renal Function in Patients with Shock and with Elevated Central Venous Pressure

Launched by UNIVERSITY HOSPITAL, ANGERS · Dec 14, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Mean Arterial Pressure Central Venous Pressure Renal Function

ClinConnect Summary

This clinical trial is looking at how increasing blood pressure affects kidney function in patients who are experiencing shock, which is a serious condition where the body doesn't get enough blood flow. Specifically, the study wants to see if raising the average blood pressure can help improve kidney performance in patients who also have high pressure in their veins. The trial is currently recruiting adult participants aged 18 and older who are experiencing low blood pressure and require medication to support their heart function.

To be eligible for this study, patients need to have certain conditions, such as needing medication like norepinephrine to manage their blood pressure and having a specific level of pressure in their veins. However, there are some important exclusions, like not being able to participate if a patient is not producing urine or if they are pregnant. Participants in this trial will be closely monitored, and their kidney function will be assessed to understand the effects of the treatment. This research aims to find better ways to help patients in critical conditions, so their kidneys can function properly while they recover.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (≥ 18 years old )
  • Arterial hypotension requiring the etablishment of catecholamines
  • Norepinephrine dose ⩾ 0.1µg/kg/min at the inclusion
  • High central venous pressure ≥ 12mmHg
  • Cardiac output monitoring (PICCO or Swan Ganz)
  • Exclusion Criteria:
  • Anuria
  • Patient with an emergency indication of renal replacement therapy (severe hyperkalemia, severe metabolical acidosis with pH \<7.15, acute pulmonary edema due to fluid overload resulting in severe hypoxemia, serum urea concentration \> 40 mmol/l)
  • Pregnant, lactating or parturient woman
  • Patient deprived of liberty by judicial or administrative decision
  • Patient with psychiatric compulsory care
  • Patient subject to legal protection measures
  • Patients with do-no-reanimate order or withdrawal of life sustaining support

About University Hospital, Angers

The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.

Locations

Angers, , France

La Roche Sur Yon, , France

Patients applied

0 patients applied

Trial Officials

Pierre ASFAR, MD PhD

Principal Investigator

Angers University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials